Submission Details
| 510(k) Number | K191013 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 17, 2019 |
| Decision Date | September 10, 2019 |
| Days to Decision | 146 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K191013 is an FDA 510(k) clearance for the Welch Allyn Diagnostic Cardiology Suite 2.X.X with Spirometry option, a Spirometer, Diagnostic (Class II — Special Controls, product code BZG), submitted by Welch Allyn, Inc. (Milwaukee, US). The FDA issued a Cleared decision on September 10, 2019, 146 days after receiving the submission on April 17, 2019. This device falls under the Anesthesiology review panel. Regulated under 21 CFR 868.1840.
| 510(k) Number | K191013 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 17, 2019 |
| Decision Date | September 10, 2019 |
| Days to Decision | 146 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | BZG — Spirometer, Diagnostic |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.1840 |